AbbVie (ABBV)
(Delayed Data from NYSE)
$193.62 USD
+0.68 (0.35%)
Updated Sep 19, 2024 04:03 PM ET
After-Market: $193.59 -0.03 (-0.02%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth C Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
ABBV 193.62 +0.68(0.35%)
Will ABBV be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for ABBV based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ABBV
AbbVie (ABBV) Stock Dips While Market Gains: Key Facts
RHHBY or ABBV: Which Is the Better Value Stock Right Now?
ABBV: What are Zacks experts saying now?
Zacks Private Portfolio Services
TEVA Stock Rises 72.5% This Year: Time to Buy, Sell or Hold?
AbbVie (ABBV) Is Considered a Good Investment by Brokers: Is That True?
FDA Grants Label Expansion to J&J's Tremfya in Ulcerative Colitis
Other News for ABBV
Interesting ABBV Put And Call Options For May 2025
American Century Growth Fund Q2 2024 Commentary
Interesting ABBV Put And Call Options For December 20th
Abbie Inc Stocks Elliott Wave Technical Analysis - Wednesday, September 18,
JMP Securities healthcare analysts hold an analyst/industry conference call